Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Glaukos (GKOS)

Glaukos Q4 sales up 28% to $105.5 million; 2025 sales guidance $475-$485 million

Positive Impact 3 of 5 earnings Written later

Glaukos reported fourth-quarter 2024 net sales of $105.5 million, up 28% from a year earlier, and full-year 2024 net sales of $383.5 million, up 22%. The company also introduced 2025 net sales guidance of $475 million to $485 million, while its GAAP net loss narrowed to $33.6 million from $36.8 million a year earlier.

Key points

  • Q4 2024 net sales were $105.5 million, up 28% year over year, and GAAP net loss was $33.6 million, or $0.60 per diluted share, versus $0.75 a year earlier.
  • FY 2024 net sales were $383.5 million, up 22%; GAAP net loss was $146.4 million, or $2.77 per diluted share.
  • Q4 2024 GAAP gross margin was approximately 73%, compared with approximately 77% in Q4 2023.
  • The company introduced 2025 net sales guidance of $475 million to $485 million and ended 2024 with approximately $324 million in cash, short-term investments and restricted cash, and no debt.

The filing

CompanyGlaukos (GKOS)
Form8-K, current report
Filed with the SECFeb 20, 2025, 4:10 PM ET
Accession number0001558370-25-001217

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:12 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 20, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.